OPM MEG in Pre-surgical Mapping for Patients With Epilepsy
Evaluating Novel OPM-magnetoencephalography in Pre-surgical Mapping for Patients With Epilepsy
1 other identifier
observational
20
1 country
1
Brief Summary
Magnetoencephalography, or "MEG", is a brain-scanning method which has been available for many years. It is used in the UK and worldwide to help patients with epilepsy, who need surgery to resolve their seizures. The MEG scan can help inform the surgeon about where to operate, by mapping the abnormal brain activity caused by epilepsy. During a traditional MEG recording, patients sit very still with their head in a rigid helmet which houses many tiny sensors. This can be uncomfortable, and there are additional problems if the patient is a child, because the helmet is often too big. It is not possible to record useful data from the very youngest children with a traditional MEG scanner. But there is a new generation of MEG systems, called OPM-MEG, which employ lightweight sensors housed in a kind of hat. The hat can be appropriately sized for children, and the patient can move comfortably. The new systems are also more cost-effective to run. It is important to know whether the accepted clinical protocols for using MEG in planning epilepsy surgery can be directly transferred to OPM-MEG. It is also important to understand how the patient experience compares across systems. In this project, 20 volunteer patients will be recruited from among those children already having routine pre-surgical MEG recordings Aston University. They will be invited to participate in an OPM-MEG recording in the same facility at Aston University, so that data from the new OPM-MEG device can be compared with the data from the old MEG scanner. Data analysis pipelines will be streamlined, and the accuracy of the results compared to determine whether the improved sensor arrangement for children in the OPM-MEG system leads to better localisation of epileptiform activity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jun 2025
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 17, 2025
CompletedFirst Submitted
Initial submission to the registry
January 19, 2026
CompletedFirst Posted
Study publicly available on registry
January 30, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 30, 2027
January 30, 2026
January 1, 2026
2 years
January 19, 2026
January 27, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Comparative localisations of epileptiform activity
Interictal epileptiform activity recorded in the OPM-MEG data will be localised with standard techniques, and resulting brain activity maps compared with those obtained in cryogenic MEG data that is shared into the study.
Within 3 months of referral
Study Arms (1)
Children with epilepsy
Children with refractory epilepsy who are candidates for neurosurgery and have been referred for a clinical MEG scan.
Eligibility Criteria
The study population is all children who are in the care of Birmingham Children's Hospital Epilepsy Surgery Service, who have been referred to Aston University for a clinical MEG scan as candidates for neurosurgery.
You may qualify if:
- Patients who are capable of giving informed assent, and have a person with parental responsibility capable of giving informed consent on their behalf.
- Male or female.
- Patients between the age of 6-15 years
- Patients and caregivers with English language skills that enable informed assent/consent.
You may not qualify if:
- Patients, or parent or caregiver, who do not assent or consent to participate in the research either on that day or later.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Aston University
Birmingham, United Kingdom, B4 7ET, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Caroline WITTON, PhD
Aston University
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 3 Months
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 19, 2026
First Posted
January 30, 2026
Study Start
June 17, 2025
Primary Completion (Estimated)
June 30, 2027
Study Completion (Estimated)
September 30, 2027
Last Updated
January 30, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share
This is essentially a qualitative proof of concept study and data may not be of the required quality for sharing.